Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of angiotensin-converting enzyme or vasopeptidase inhibition on ventricular size and function in patients with heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE) echocardiographic study.
Solomon SD, Skali H, Bourgoun M, Fang J, Ghali JK, Martelet M, Wojciechowski D, Ansmite B, Skards J, Laks T, Henry D, Packer M, Pfeffer MA; OVERTURE Investigators. Solomon SD, et al. Among authors: bourgoun m. Am Heart J. 2005 Aug;150(2):257-62. doi: 10.1016/j.ahj.2004.09.056. Am Heart J. 2005. PMID: 16086927 Clinical Trial.
Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction.
Solomon SD, Skali H, Anavekar NS, Bourgoun M, Barvik S, Ghali JK, Warnica JW, Khrakovskaya M, Arnold JM, Schwartz Y, Velazquez EJ, Califf RM, McMurray JV, Pfeffer MA. Solomon SD, et al. Among authors: bourgoun m. Circulation. 2005 Jun 28;111(25):3411-9. doi: 10.1161/CIRCULATIONAHA.104.508093. Epub 2005 Jun 20. Circulation. 2005. PMID: 15967846 Clinical Trial.
Comparison of regional versus global assessment of left ventricular function in patients with left ventricular dysfunction, heart failure, or both after myocardial infarction: the valsartan in acute myocardial infarction echocardiographic study.
Thune JJ, Køber L, Pfeffer MA, Skali H, Anavekar NS, Bourgoun M, Ghali JK, Arnold JM, Velazquez EJ, Solomon SD. Thune JJ, et al. Among authors: bourgoun m. J Am Soc Echocardiogr. 2006 Dec;19(12):1462-5. doi: 10.1016/j.echo.2006.05.028. J Am Soc Echocardiogr. 2006. PMID: 17138030
Mitral regurgitation in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: prognostic significance and relation to ventricular size and function.
Amigoni M, Meris A, Thune JJ, Mangalat D, Skali H, Bourgoun M, Warnica JW, Barvik S, Arnold JM, Velazquez EJ, Van de Werf F, Ghali J, McMurray JJ, Køber L, Pfeffer MA, Solomon SD. Amigoni M, et al. Among authors: bourgoun m. Eur Heart J. 2007 Feb;28(3):326-33. doi: 10.1093/eurheartj/ehl464. Epub 2007 Jan 24. Eur Heart J. 2007. PMID: 17251259
Usefulness of right ventricular fractional area change to predict death, heart failure, and stroke following myocardial infarction (from the VALIANT ECHO Study).
Anavekar NS, Skali H, Bourgoun M, Ghali JK, Kober L, Maggioni AP, McMurray JJ, Velazquez E, Califf R, Pfeffer MA, Solomon SD. Anavekar NS, et al. Among authors: bourgoun m. Am J Cardiol. 2008 Mar 1;101(5):607-12. doi: 10.1016/j.amjcard.2007.09.115. Am J Cardiol. 2008. PMID: 18308007 Clinical Trial.
Left atrial remodelling in patients with myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALIANT Echo study.
Meris A, Amigoni M, Uno H, Thune JJ, Verma A, Køber L, Bourgoun M, McMurray JJ, Velazquez EJ, Maggioni AP, Ghali J, Arnold JM, Zelenkofske S, Pfeffer MA, Solomon SD. Meris A, et al. Among authors: bourgoun m. Eur Heart J. 2009 Jan;30(1):56-65. doi: 10.1093/eurheartj/ehn499. Epub 2008 Nov 11. Eur Heart J. 2009. PMID: 19001474
Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study.
Verma A, Meris A, Skali H, Ghali JK, Arnold JM, Bourgoun M, Velazquez EJ, McMurray JJ, Kober L, Pfeffer MA, Califf RM, Solomon SD. Verma A, et al. Among authors: bourgoun m. JACC Cardiovasc Imaging. 2008 Sep;1(5):582-91. doi: 10.1016/j.jcmg.2008.05.012. JACC Cardiovasc Imaging. 2008. PMID: 19356485 Free article. Clinical Trial.
Mechanical dyssynchrony after myocardial infarction in patients with left ventricular dysfunction, heart failure, or both.
Shin SH, Hung CL, Uno H, Hassanein AH, Verma A, Bourgoun M, Køber L, Ghali JK, Velazquez EJ, Califf RM, Pfeffer MA, Solomon SD; Valsartan in Acute Myocardial Infarction Trial (VALIANT) Investigators. Shin SH, et al. Among authors: bourgoun m. Circulation. 2010 Mar 9;121(9):1096-103. doi: 10.1161/CIRCULATIONAHA.109.863795. Epub 2010 Feb 22. Circulation. 2010. PMID: 20176989
Relationship between improvement in left ventricular dyssynchrony and contractile function and clinical outcome with cardiac resynchronization therapy: the MADIT-CRT trial.
Pouleur AC, Knappe D, Shah AM, Uno H, Bourgoun M, Foster E, McNitt S, Hall WJ, Zareba W, Goldenberg I, Moss AJ, Pfeffer MA, Solomon SD; MADIT-CRT Investigators. Pouleur AC, et al. Among authors: bourgoun m. Eur Heart J. 2011 Jul;32(14):1720-9. doi: 10.1093/eurheartj/ehr185. Epub 2011 May 24. Eur Heart J. 2011. PMID: 21609974 Clinical Trial.
Right ventricular function, pulmonary pressure estimation, and clinical outcomes in cardiac resynchronization therapy.
Campbell P, Takeuchi M, Bourgoun M, Shah A, Foster E, Brown MW, Goldenberg I, Huang DT, McNitt S, Hall WJ, Moss A, Pfeffer MA, Solomon SD; Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) Investigators. Campbell P, et al. Among authors: bourgoun m. Circ Heart Fail. 2013 May;6(3):435-42. doi: 10.1161/CIRCHEARTFAILURE.112.000127. Epub 2013 Mar 22. Circ Heart Fail. 2013. PMID: 23524528 Clinical Trial.
19 results